Four Jones Day lawyers named 2020 "Rising Stars" by Law360
The global law firm Jones Day is pleased to announce that four of the Firm's lawyers are among Law360's "Rising Stars" for 2020. The annual feature recognizes the profession's top legal talent under the age of 40. According to Law360, "Winners were selected based on their career accomplishments in their respective disciplines."
Law360 will profile the Jones Day Rising Stars listed below in the coming weeks.
- Jennifer Everett, Cybersecurity, Privacy & Data Protection Practice (Washington), Cybersecurity Rising Star
- Sarah Geers, Intellectual Property Practice (New York), Life Sciences Rising Star
- Eva Monard, Government Regulation Practice (Brussels), International Trade Rising Star
- Yaakov Roth, Issues & Appeals Practice (Washington), Appellate Rising Star
Law360 named 176 Rising Stars, across 38 practice areas, from more than 1,300 submissions.
Ms. Everett focuses her practice on developing and maintaining sustainable privacy and cybersecurity governance programs and designing and building effective cross-border privacy and cybersecurity programs consistent with state, federal, and international cybersecurity laws. She has extensive experience advising clients on compliance with the GDPR and CCPA, among other laws, and routinely develops written policies, procedures, and standards and conducts data privacy impact assessments. She regularly counsels clients on privacy and data protection related to employee monitoring, workplace investigations, personal device (BYOD) policies, employee background checks, and e-discovery. Ms. Everett possesses the ability to coordinate seamlessly across disciplines and regions to provide clients the most up-to-date advice on constantly evolving laws and trends.
Ms. Geers represents pharmaceutical clients in complex intellectual property litigation in a variety of venues, including in district court, arbitration, and at the PTAB. She understands the unique challenges faced by the pharmaceutical industry from both business and legal perspectives, leveraging her grasp of the Research & Development side of the business gained as a pharmaceutical chemist for four years at Merck. She brings this multidimensional industry insight to her representation of some of the world’s most successful branded pharmaceutical and biotechnology companies, such as Bristol Myers Squibb, Merck, and Purdue Pharma. Clients draw upon her knowledge in Hatch-Waxman and other patent infringement actions, inter partes review proceedings, and trade secret and misappropriation actions, many of which involve cross-jurisdictional disputes spanning the globe.
Ms. Monard has advised clients in more than 70 anti-dumping, anti-subsidy, and safeguard investigations in more than 10 jurisdictions. She has exceptional experience in terms of litigating cases before the General Court, the Court of Justice, WTO panels, and the WTO Appellate Body. She has won several landmark cases on trade matters brought before the General Court / Court of Justice with a significant impact on the practice of the European Commission. While still in her 20s, she argued cases during the oral hearing before a WTO panel and before the WTO Appellate Body. She also has extensive experience in the area of customs, sanctions and export controls, where she assists several multinationals in investigations and more generally to help them navigate the complex web of rules in this field. Highly regarded among her peers, Ms. Monard has been hailed by Chambers and Partners as "probably the best trade lawyer of her generation."
Mr. Roth's cases have set precedents in areas ranging from high-profile federal constitutional issues to obscure ERISA doctrines, and his client roster includes individuals, non-profits, and large corporations. He works closely with clients and subject matter experts to steer their litigation matters in the right direction often even before a complaint is filed, and to identify and prevail on the key legal issues once they are in court. Mr. Roth is a passionate advocate for First Amendment liberties, defending the rights of prison inmates and multinational corporations alike. He argued—and won—his first Supreme Court case this year. He has drafted multiple certiorari petitions that the Court has granted, and was the primary drafter of the merits briefs not only in each of those cases, but also in a number of others as counsel for respondent.